Efficacy of ECT in the treatment of pharmacoresistant depressive disorder from patients point of view;Efektivita EKT v léčbě farmakorezistentní depresivní poruchy z pohledu pacientů

Psychiatrie

Volumn 9, Issue 4, 2005, Pages 282-285

  Kopeček, Miloslav ^a   Bareš, Martin ^a   Seifertová, Dagmar ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

Author keywords

Depressive disorder; Electroconvulsion therapy; Self report inventories

Indexed keywords

ANESTHETIC AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ATROPINE; SUXAMETHONIUM; THIOPENTAL;

ADULT; AGE; ARTICLE; BECK ANXIETY INVENTORY; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; DEPRESSION; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; MALE; REMISSION; RESPIRATORY TRACT DISEASE; SELF REPORT;

EID: 28644431798     PISSN: 12117579     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (Revision). Am J Psychiatry 2000;(Suppl.):157.
2. Baudiš P. Elektrokonvulzivní léčbav České republice v letech 1981-1989. Čs. psychiatrie 1992; 88:41-47
3. Baudiš P, Trykarová J. Zvyšuje souč asné podáváni imipraminu účinnost elektrošoků? Čs. Psychiatrie 1968; 64:95-100.
4. Beck AT, Steer RA. Beck Anxiety Inventory Manual. San Antonio, TX: The Psychological Corporation 1990.
5. Beck AT, Beck RW. Screening depressed patients in family practice. A rapid technic. Postgrad Med 1972; 52:81-5.
6. Beck AT, Rial WY, Rickels K. Short form of depression inventory: cross-validation. Psychol Rep 1974; 34:1184-6.
7. Bremner JD, Innis RB, White T, Fujita M, Silbersweig D, Goddard AW, Staib L, Stern E, Cappiello A, Woods S, Baldwin R, Charney DS. SPECT [I-123]iomazenil measurement of the benzodiazepine receptor in panic disorder. Biol Psychiatry 2000; 47:96-106.
8. Carpenter LL, Yasmin S, Price LH. A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapme. Biol Psychiatry 2002; 51:183-8.
9. Fitzgerald PB, Brown TL, Marston NA, Daskalakis ZJ, De Castella A, Kulkarni J. Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial. Arch. Gen Psychiatry 2003; 60:1002-1008.
10. Fridrich P, Kott A, Kozelek P, Žukov I. Pro koho je vhodná elektrokonvulzivní terapie. v Raboch J, Zrzavecká I, Doubek P, Anders M. Česká psychiatrie a svět. Galén. Praha 2004; 46-47.
11. Goppoldová E, Motlová L, Dragomirecká E, Hájek T. Změna subjektivní kvalíty života a klinického stavu v průběhu psychiatrické hospitalizace. Existují rozdíly mezi diagnostickými kategoriemi? Psychiatrie 2004; 8: 267-273.
12. Grunhaus L, Dannon PN, Schreiber S, Dolberg OH, Amiaz R, Ziv R et al. Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in tne treatment of nondelusional major depressive disorder: an open study. Biol Psychiatry 2000; 47: 314-324.
13. Grunhaus L, Schreiber S, Dolberg OT, Polak D, Dannon PN. A randomized controlled comparison of electroconvulsive therapy and repetitive transcranial magnetic stimulation in severe and resistant nonpsychotic major depression. Biol. Psychiatry 2003; 53:324-331.
14. Hrdlička M. Elektrokunvulzivní terapie. Galén 1999.
15. Hrdlička M, Blatný M, Moráň M, Maňasová I. Elektrokojivulzivní terapie a souběžná léčba psychofarmaky: účinnost kombinace. Česká a slovenská psychiatrie 1999; 95:201-211.
16. Hrdlička M, Blatný M, Urbánek T, Moráň M, Maňasová I. Elektrokonvulzivní terapie: ovlivňuje anamnéza farmakorezistentní odpovëd'? Česká a slovenská psychiatrie 2001; 97:56-59.
17. Husain MM, Rush AJ, Fink M, Knapp R, Petrides G, Rummans T, Biggs MM, O'Connor K, Rasmussen K, Litle M, Zhao W, Bernstein HJ, Smith G, Mueller M, McClintock SM, Bailine SH, Kellner CH. Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a Consortium for Research in ECT (CORE) report. J Clin Psychiatry 2004; 65:485-91.
18. Janicak PG, Dowd SM, Martis B, Alam D, Beedle D, Krasuski J et al. Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: preliminary results of a randomized trial. Biol Psychiatry 2002; 51:659-667.
19. Kindler S, Shapira B, Hadjez J, Abramowitz M, Brom D, Lerer B. Factors influencing response to bilateral electroconvulsive therapy in major depression. Convuls Ther 1991; 7:245-254.
20. Klein E, Kreinin I, Chistyakov A, Koren D, Mecz L, Marmur S et al. Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: a double-blind controlled study. Arch Gen Psychiatry 1999; 56:315-320.
21. Lam RW, Wan DDC, Cohen NL, Kennedy SH. Combining antidepressants for treatment - resistant depression: a review. J Clin Psychiatry 2002; 63:685-693.
22. McCall WV, Dunn A, Rosenquist PB. Quality of life and function after electroconvulsive therapy. Br J Psychiatry 2004; 185:405-9.
23. Medical Research Council Clinical trial in the treatment of depressive illness Br J Med 1965; 5439:881-886.
24. Papakostas GI, Petersen TJ, Nierenberg AA, Murakami JL, Alpert JE, Rosenbaum JF, Fava M. Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder. J Clin Psychiatry 2004; 65:217-21.
25. Petrides G, Fink M, Hussain MM. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT 2001; 17:244-253.
26. Poirier MF, Boyer P. Venlafaxine and paroxetine in treatment-resistant depression. Double-blind, randomised comparison. Br J Psychiatry 1999; 175:12-6.
27. Pridmore S, Bruno R, Turnier-Shea Y, Reid P, Rybak M. Comparison of unlimited numbers of rapid transcranial magnetic stimulation (rTMS) and ECT treatment sessions in major depressive episode. Int J Neuropsychopharmacol 2000; 3:129-134.
28. PrudicJ, Haskett RF, Mulsant B, Malone KM, Pettinati HM, Stephens S, Greenberg R, Rifas SL, Sackeim HA. Resistance to antidepressant medications and short term clinical response to ECT. Am J Psychiatry 1996; 153:985-992.
29. Prudic J, Olfson M, Marcus SC, Fuller RB, Sackeim HA. Effectiveness of electroconvulsive therapy in community settings. Biol Psychiatry 2004; Report of The NIMH-NIH Consensus Development Conference On Convulsive Therapy, Psychopharmacology Bulletin, NIMH, 1986; 22:445-502.
30. Rose D, Fleischmann P, Wykes T, Leese M, Bindman J. Patients' perspectives on electroconvulsive therapy: systematic review. BMJ 2003; 326:1363.
31. Roubíček J. Šokové léč ení duševních chorob. Lékařské knihkupectví a nakladatelství. 1946.
32. Seifertová D. Elektrokonvulzivní terapie. In: Seifertová D, Praško J, Höschl C. (eds.): Postupy v léčbě psychických poruch. Praha, Academia Medica Pragensis, 2004.
33. Sanacora G, Mason GF, Rothman DL, Hyder F, Ciarcia JJ, Ostroff RB, Berman RM, Krystal JH. Increased cortical GABA concentrations in depressed patients receiving ECT. Am J Psychiatry 2003; 160: 577-579.
34. Thase ME. New approaches to managing difficult-to-treat depressions. J Clin Psychiatry 2003; 64(Suppl. 1):3-4.
35. Thase ME, Entsuah AR, Rudolph RL. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 2001; 178:214-224.
36. Trivedi MH, Rush AJ, Ibrahim HM, Carmody TJ, Biggs MM, Suppes T, Crismon ML, Shores-Wilson K, Toprac MG, Dennehy EB, Witte B, Kashner TM. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med 2004; 34:73-82.
37. UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 2003; 361:799-808.
38. van den Broek WW, de Lely A, Mulder PG, Birkenhager TK, Bruijn JA. Effect of antidepressant medication resistance on short-term response to electroconvulsive therapy. J Clin Psychopharmacol 2004; 24:400-403.